PHF1: A Potential Drug Target and Biomarker (G5252)
PHF1: A Potential Drug Target and Biomarker
Phosphatidylinositol (PI) phosphate (PHF1) is a cell signaling molecule that plays a crucial role in various cellular processes, including cell signaling, intracellular signaling, and cytoskeletal organization.PHF1 has been identified as a potential drug target and biomarker in various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases.
PHF1 functions as a negative regulator of the protein kinase A (PKA).PKA is a key enzyme involved in many cellular processes, including cell signaling, DNA replication, and cell survival.PHF1 functions by binding to the active site of PKA, inhibiting its catalytic activity and regulating the activity of other cellular signaling pathways.
PHF1 has been shown to play a role in various diseases and conditions, including cancer, neurodegenerative diseases, and cardiovascular diseases. For example, studies have shown that PHF1 levels are often elevated in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, PHF1 has been shown to be involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease.
Furthermore, PHF1 has also been shown to be involved in the regulation of cellular signaling pathways that are important for cardiovascular disease, including angiogenesis, inflammation, and cellular signaling. For example, studies have shown that PHF1 can regulate the angiogenesis of cancer cells, which can lead to the formation of new blood vessels that can contribute to the development of cancer.
In addition to its role in cellular signaling, PHF1 has also been shown to play a role in the regulation of cellular structure and cytoskeletal organization.PHF1 has been shown to interact with various cellular signaling proteins, including the protein tyrosine phosphatase (PTP) and the protein src.
PHF1 has also been shown to play a role in the regulation of cellular processes that are important for the development and progression of diseases. For example, studies have shown that PHF1 can regulate the migration of cancer cells, which can contribute to their spread and the development of invasive tumors.
In conclusion, PHF1 is a protein that has been shown to play a role in various diseases and conditions, including cancer, neurodegenerative diseases, and cardiovascular diseases.Because of its role in cellular signaling and its involvement in the regulation of cellular structure and cytoskeletal organization, PHF1 is a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand the role of PHF1 in these diseases and to develop effective treatments.
Protein Name: PHD Finger Protein 1
Functions: Polycomb group (PcG) that specifically binds histone H3 trimethylated at 'Lys-36' (H3K36me3) and recruits the PRC2 complex. Involved in DNA damage response and is recruited at double-strand breaks (DSBs). Acts by binding to H3K36me3, a mark for transcriptional activation, and recruiting the PRC2 complex: it is however unclear whether recruitment of the PRC2 complex to H3K36me3 leads to enhance or inhibit H3K27me3 methylation mediated by the PRC2 complex. According to some reports, PRC2 recruitment by PHF1 promotes H3K27me3 and subsequent gene silencing by inducing spreading of PRC2 and H3K27me3 into H3K36me3 loci (PubMed:18285464, PubMed:23273982). According to another report, PHF1 recruits the PRC2 complex at double-strand breaks (DSBs) and inhibits the activity of PRC2 (PubMed:23142980). Regulates p53/TP53 stability and prolonges its turnover: may act by specifically binding to a methylated from of p53/TP53
More Common Targets
PHF10 | PHF11 | PHF12 | PHF13 | PHF14 | PHF19 | PHF2 | PHF2-ARID5B complex | PHF20 | PHF20L1 | PHF21A | PHF21B | PHF23 | PHF24 | PHF2P1 | PHF2P2 | PHF3 | PHF5A | PHF6 | PHF7 | PHF8 | PHGDH | PHGR1 | PHIP | PHKA1 | PHKA1-AS1 | PHKA2 | PHKA2-AS1 | PHKB | PHKG1 | PHKG2 | PHLDA1 | PHLDA2 | PHLDA3 | PHLDB1 | PHLDB2 | PHLDB3 | PHLPP1 | PHLPP2 | Phosphatidylinositol 3-kinase (PI3K) | Phosphatidylinositol 3-kinase complex (PIK3C3, PIK3R4) | Phosphatidylinositol 4-Kinase (PI4K) | Phosphatidylinositol 4-Kinase beta (PI4K-beta) | Phosphatidylinositol 4-phosphate 5-kinase | Phosphatidylinositol N-acetylglucosaminyltransferase | Phosphatidylinositol-5-phosphate 4-kinase | PHOSPHO1 | PHOSPHO2 | PHOSPHO2-KLHL23 | Phosphodiesterase | Phosphodiesterase 1 (PDE1) | Phosphodiesterase 6 (PDE6) | Phosphodiesterase 8 (nons | Phosphodiesterase IV (PDE4) | Phosphoglucomutase 5 pseudogene 1 | Phosphoglycerate kinase | Phospholipase A | Phospholipase A2 | Phospholipase A2, Cytosolic | Phospholipase A2, Secretory (sPLA2) | Phospholipase C | Phospholipase D | Phosphorylase kinase | PHOX2A | PHOX2B | PHPT1 | PHRF1 | PHTF1 | PHTF2 | PHYH | PHYHD1 | PHYHIP | PHYHIPL | PHYKPL | PI15 | PI16 | PI3 | PI4K2A | PI4K2B | PI4KA | PI4KAP1 | PI4KAP2 | PI4KB | PIANP | PIAS1 | PIAS2 | PIAS3 | PIAS4 | PIBF1 | PICALM | PICART1 | PICK1 | PICSAR | PID1 | PIDD1 | PIERCE1 | PIERCE2 | PIEZO1 | PIEZO2 | PIF1